A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy

[1] Su RM(2003)Signet-ring stromal tumor of the ovary: a case report Int J Gynecol Cancer 13 90-93

[2] Chang KC(2010)Primary signet ring cell mucinous ovarian carcinoma: a case report and literature review Case Rep Oncol 3 451-457

[3] Chou CY(2012)A case of primary signet ring cell carcinoma of the ovary The J Fukuoka College Obstet Gynecol 36 13-16

[4] El-Safadi S(2014)Primary ovarian mucinous carcinoma with signet ring cells - report of a rare case J Clin Diagn Res 8 FD12-FD13

[5] Stahl U(2018)Primary ovarian signet ring cell carcinoma: a rare case report Mol Clin Oncol 9 211-214

[6] Tinneberg HR(2003)Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study J Clin Oncol 21 3194-3200

[7] Hackethal A(2003)Arbeitsgemeinschaft Gynäkologische Onkologie ovarian Cancer study group. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer J Natl Cancer Inst 95 1320-1329

[8] Muenstedt K(1896)Uber das fibrosarcoma ovarii mucocellulare (carcinomatodes) Arch Gynecol 50 287-321

[9] Ogawa S(1968)Primary Krukenberg tumor of ovary. Review of literature and case report Cancer 22 1199-1207

[10] Inoue S(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anti-Cancer Drugs 7 548-557

[1] Su RM(2003)Signet-ring stromal tumor of the ovary: a case report Int J Gynecol Cancer 13 90-93

[2] Chang KC(2010)Primary signet ring cell mucinous ovarian carcinoma: a case report and literature review Case Rep Oncol 3 451-457

[3] Chou CY(2012)A case of primary signet ring cell carcinoma of the ovary The J Fukuoka College Obstet Gynecol 36 13-16

[4] El-Safadi S(2014)Primary ovarian mucinous carcinoma with signet ring cells - report of a rare case J Clin Diagn Res 8 FD12-FD13

[5] Stahl U(2018)Primary ovarian signet ring cell carcinoma: a rare case report Mol Clin Oncol 9 211-214

[6] Tinneberg HR(2003)Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study J Clin Oncol 21 3194-3200

[7] Hackethal A(2003)Arbeitsgemeinschaft Gynäkologische Onkologie ovarian Cancer study group. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer J Natl Cancer Inst 95 1320-1329

[8] Muenstedt K(1896)Uber das fibrosarcoma ovarii mucocellulare (carcinomatodes) Arch Gynecol 50 287-321

[9] Ogawa S(1968)Primary Krukenberg tumor of ovary. Review of literature and case report Cancer 22 1199-1207

[10] Inoue S(1996)Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anti-Cancer Drugs 7 548-557